|
Hyperpolarized Carbon C 13 Pyruvate Clinical Trials
5 actively recruiting trials across 2 locations
Also known as: HP C13 pyruvate, Hyperpolarized 13C-Pyruvate, Hyperpolarized Pyruvate (13C)
San Francisco, California3 trials
Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma
University of California, San Francisco
Phase 1
Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance
University of California, San Francisco
Phase 2
Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma
University of California, San Francisco
Phase 1
Houston, Texas2 trials
An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy
M D Anderson Cancer Center
Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
M D Anderson Cancer Center
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.